A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma

Clinical trial NCT00920556 · TERMINATED

Trial details

NCT number: NCT00920556
Sponsor: Sirtris, a GSK Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2009-03-30
Primary completion: 2010-11-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.